SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption
SS Innovations International announced that its SSi Mantra surgical robotic system has been used in over 10,500 procedures across 11 countries, highlighting the system's rapid adoption and potential to democratize robotic surgery.
SS Innovations International, Inc. (Nasdaq: SSII) announced today that its SSi Mantra surgical robotic system has been used in more than 10,500 cumulative surgeries as of April 30, 2026, marking a significant milestone for the company. The achievement underscores the growing global acceptance of the SSi Mantra, which has expanded its installed base to over 200 systems across 11 countries since its commercial launch in August 2022.
The milestone includes more than 500 cardiac procedures, 170 telesurgeries, and 125 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the system, which has been utilized to perform over 170 different types of procedures. This breadth of use indicates the system's versatility and the effectiveness of the company's training programs.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, commented on the achievement: "Reaching 10,500 cumulative surgeries in such a short time span reflects the SSi Mantra’s advanced technology, differentiated features, ease of training, user-friendliness, and clear cost advantages." He emphasized the company's mission to "help democratize access to world-class surgical robotic care."
The SSi Mantra is a modular, multi-arm system with features including 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, and a large 3D 4K monitor. It supports over 40 different types of robotic endo-surgical instruments, including 5mm instruments for pediatric and ENT surgeries. The optional SSi MantrAsana Tele Surgeon Console enables telesurgery, a capability that has been demonstrated in 170 procedures.
The news is significant as it highlights the rapid adoption of a cost-effective robotic surgical system in a market traditionally dominated by more expensive competitors. By making robotic surgery more affordable and accessible, SS Innovations is addressing a critical need in global healthcare, particularly in emerging markets. The company's expansion into 11 countries and the training of over 2,100 physicians suggest that the SSi Mantra is gaining traction as a viable alternative for hospitals seeking to offer advanced surgical capabilities.
For more information about SS Innovations and the SSi Mantra, visit the company's website at ssinnovations.com or its LinkedIn page. The latest news and updates are available in the company's newsroom at https://tinyurl.com/ssiinewsroom.